News Focus
News Focus
Followers 42
Posts 2800
Boards Moderated 0
Alias Born 04/04/2014

Re: AnG5640 post# 9716

Friday, 10/31/2014 3:54:23 PM

Friday, October 31, 2014 3:54:23 PM

Post# of 27689
IBIO would not be the primary company doing the growing. Their tech. will be licensed to increase the yield of the antibodies that make up ZMapp.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News